Evidence map›Paper›PMID 29505607›Full record

ArticlePloS one2018

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.

Guisong Wang, Anna Vachaparampil Mathew, Haiyi Yu, Lei Li, Liyun He, Wei Gao, Xiaodan Liu, Yanhong Guo, Jaeman Byun, Jifeng Zhang and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Oxidative modification of HDL by lipid aldehydes impacts HDL function.Archives of biochemistry and biophysics · 2022
    Review
  7. Review
  8. Proteomic Studies of Blood and Vascular Wall in Atherosclerosis.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Guisong WangDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
Anna Vachaparampil MathewDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Haiyi YuDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
Lei LiDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
Liyun HeDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
Wei GaoDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
Xiaodan LiuDepartment of Medicine, Nephrology, First Affiliated Hospital, China Medical University, Shenyang, China.
Yanhong GuoDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Jaeman ByunDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Jifeng ZhangDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Y Eugene ChenDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Subramaniam PennathurDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID 0000-0003-3628-6883
University of Michigan · USMinistry of Education of the People's Republic of China · CNFirst Hospital of China Medical University · CN

Funding

University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PENNATHUR, SUBRAMANIAM · 2008 to 2022
$12.9M
Myeloperoxidase, Chronic Kidney Disease and AtherosclerosisK08HL130944 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MATHEW, ANNA VACHAPARAMPIL · 2016 to 2021
$893k
NHLBI NIH HHS K08 HL130944NIDDK NIH HHS P30 DK081943NIH HHS P30DK081943
6 · The paper itself

Abstract

High density lipoprotein (HDL) cholesterol levels and cholesterol efflux capacity (CEC) are inversely correlated with coronary artery disease (CAD) risk. Myeloperoxidase (MPO) derived oxidants and HDL proteome changes are implicated in HDL dysfunction in subjects with CAD in the United States; however, the effect of MPO on HDL function and HDL proteome in ethnic Chinese population is unknown. We recruited four matched ethnic Chinese groups (20 patients each): subjects with 1) low HDL levels (HDL levels in men <40mg/dL and women <50mg/dL) and non-CAD (identified by coronary angiography or cardiac CT angiography); 2) low HDL and CAD; 3) high HDL (men >50mg/dL; women >60mg/dL) with no CAD; and 4) high HDL with CAD. Serum cytokines, serum MPO levels, serum CEC, MPO-oxidized HDL tyrosine moieties, and HDL proteome were assessed by mass spectrometry individually in the four groups. The cytokines, MPO levels, and HDL proteome profiles were not significantly different between the four groups. As expected, CEC was depressed in the entire CAD group but more specifically in the CAD low-HDL group. HDL of CAD subjects had significantly higher 3-nitrotyrosine than non-CAD subjects, but the MPO-specific 3-chlorotyrosine was unchanged; CEC in the CAD low-HDL group did not correlate with either HDL 3-chlorotyrosine or 3-nitrotyrosine levels. Neither 3-chlorotyrosine, which is MPO-specific, nor 3-nitrotyrosine generated from MPO or other reactive nitrogen species was associated with CEC. MPO mediated oxidative stress and HDL proteome composition changes are not the primary cause HDL dysfunction in Chinese subjects with CAD. These studies highlight ethnic differences in HDL dysfunction between United States and Chinese cohorts raising possibility of unique pathways of HDL dysfunction in this cohort.

Indexed as

ProteomeAnimalsCase-Control StudiesCell LineChinaCohort StudiesCoronary Artery DiseaseCross-Sectional StudiesCytokinesFemaleHumansLipoproteins, HDLMaleMiceMiddle AgedOxidation-ReductionCytokinesLipoproteins, HDLPeroxidaseProteome

Identifiers

PMID29505607
PMCPMC5837105
OpenAlexW2791322659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.